ADGRL4 and central nervous system cancer: Recently, in vitro and in vivo experiments demonstrated that ELTD1 plays a very important role in proliferation, migration, and invasion of glioma cells, and its overexpression was correlated with poor overall survival (OS) and disease–free survival (DFS) rates in glioma patients.